Deniz Karakaya

Deniz Karakaya

Auto-generated profile, based on publicly available information

Deniz Karakaya

Department of Pediatric Nephrology, Ankara Etlik City Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
DKDeniz Karakaya
Deniz Karakaya
TGTülin Güngör
Tülin Güngör
EÇEvrim Kargın Çakıcı
Evrim Kargın Çakıcı
FYFatma Yazılıtaş
Fatma Yazılıtaş
EÇEvra Çelikkaya
Evra Çelikkaya
MBMehmet Bülbül
Mehmet Bülbül

25 July 2023 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
DKDeniz Karakaya
Deniz Karakaya
AYAysun Çaltık Yılmaz
Aysun Çaltık Yılmaz
TGTülin Güngör
Tülin Güngör
BKBahriye Uzun Kenan
Bahriye Uzun Kenan
EÇEvra Çelikkaya
Evra Çelikkaya
EÇEvrim Kargın Çakıcı
Evrim Kargın Çakıcı

13 April 2022 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
TGTülin Güngör
Tülin Güngör
FYFatma Yazılıtaş
Fatma Yazılıtaş
EÇEvrim Kargın Çakıcı
Evrim Kargın Çakıcı
DKDeniz Karakaya
Deniz Karakaya
MBMehmet Bülbül
Mehmet Bülbül

2 January 2024 in Postgraduate Medicine
Verified
Journal Article
Closed access
FYFatma Yazılıtaş
Fatma Yazılıtaş
EÇEvrim Kargın Çakıcı
Evrim Kargın Çakıcı
DKDeniz Karakaya
Deniz Karakaya
TGTülin Güngör
Tülin Güngör
EÇEvra Çelikkaya
Evra Çelikkaya
MBMehmet Bülbül
Mehmet Bülbül
The importance of immature granulocytes (IGs) in most infectious and inflammatory diseases has been highlighted. This study aimed to determine the clinical usability and importance of changes in the peripheral complete blood count profile, including IG percentage (IG%) and IG count (IG#), during the relapse and remission phases in pediatric nephrotic syndrome (NS) patients. This retrospective observational study was performed at a tertiary care hospital between February 2020 and August 2022. Demographic characteristics and laboratory parameters were recorded. The IG count and IG% were measured using an automated hematological analyzer. IG% and IG# were both higher during the relapse phase of NS than during the remission phase (0.29%±0.14%, versus 0.23%±0.14%, p = 0.037 and 0.027 ± 0.015 × 103/µL, versus 0.018 ± 0.014 × 103/µL, p = 0.005, respectively). The neutrophil to lymphocyte ratio (NLR), platelet (PLT), white blood cell (WBC), and neutrophil counts had a strong positive correlation with IG# (r = 0.397, p < 0.001; r = 0.352, p < 0.001; r = 0.622, p < 0.001; r = 0.660, p < 0.001, respectively). The NLR, PLT, WBC, and neutrophil counts had a strong positive correlation with IG% (r = 0.348, p < 0.001; r = 0.187, p = 0.039; r = 0.303, p = 0.001; r = 0.426, p < 0.001, respectively). Receiver operating characteristic curve analysis showed that IG# had the best AUC value of 0.69 (95% CI: 0.58-0.77; p = 0.001) for the relapse phase of NS with a cutoff value of 0.025 × 103/µL (sensitivity: 81.0%, specificity: 78.1%). It is probable that a high level of immature granulocyte count has a positive correlation for NS relapse in pediatric patients. The IG % and IG# can be used together as biomarkers of inflammation in pediatric NS relapse.

16 March 2021 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TGTülin Güngör
Tülin Güngör
FYFatma Yazılıtaş
Fatma Yazılıtaş
EÇEvrim Kargın Çakıcı
Evrim Kargın Çakıcı
AEAyşe Seçil Ekşioğlu
Ayşe Seçil Ekşioğlu
EÇEvra Çelikkaya
Evra Çelikkaya
MBMehmet Bülbül
Mehmet Bülbül

22 August 2023 in Cureus
Verified
Journal Article
Open access
PDF file
DKDeniz Karakaya
Deniz Karakaya
EÇEvrim Kargın Çakıcı
Evrim Kargın Çakıcı
FYFatma Yazilitaş
Fatma Yazilitaş
MBMehmet Bülbül
Mehmet Bülbül
TGTüli̇n Güngör
Tüli̇n Güngör
EÇEvra Çeli̇kkaya
Evra Çeli̇kkaya
Aim Nephrotic syndrome is the most common childhood glomerular disorder, but data on the associated complications are limited and predisposing risk factors have not been fully defined. The aim of this study was to evaluate disease- and treatment-related acute and chronic complications in patients with childhood idiopathic nephrotic syndrome (INS), and to identify the risk factors involved in the development of complications. Methods This single-center study was performed at the pediatric nephrology department of a tertiary pediatric hospital in Turkey. The study included 411 patients with a diagnosis of childhood INS, 128 of whom had disease-related and treatment-related complications. Patients diagnosed and followed-up between January 2010 and January 2022 were evaluated retrospectively. Results Complications occurred in 31.1% of the 411 patients. Mean age at the time of diagnosis was 7.54 ± 4.37 years, and the male/female ratio was 0.9:1. Among the patients with complications, 96.9% were disease-related, and 50.8% were treatment-related complications. In older age, high proteinuria level, a low estimated glomerular filtration rate (eGFR) level at diagnosis, and female gender were significant risk factors for complication development (P = 0.000, P = 0.006, P = 0.04, and P = 0.07, respectively). Chronic kidney disease (CKD) developed in 7% of patients and 2.9% of patients had end-stage renal disease (ESRD). Additionally, three of 12 patients with progressive ESRD underwent transplantation. Also the incidence of ESRD was significantly higher in the patients with complications than in those without complications (P < 0.05). Conclusion The present findings suggest that careful monitoring of patients with childhood INS at risk for complications and implementation of personalized treatment programs can improve long-term outcomes, especially in patients that progress to ESRD and are followed-up with dialysis or transplantation as targeted therapy.